Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0225 | -3.21% | 0.6775 | 0.605 | 0.795 | - | 636,008 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 802k | -586k | -0.0003 | -23.33 | 15.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2024 17:17 | siggy, FF would have the "potential for a similar blanket rollout to save the cost of all those strokes ?" if PXS had a spare £279m "....as the government announced a five-year trial in Greater Manchester of the weight loss drug Mounjaro. Mounjaro's maker, Lilly - the world's largest pharmaceutical company - is investing £279m as part of the trial, which will look at whether using the drug will reduce worklessness and NHS use." They are nothing more than guinea pigs as Free Gear Keir looks for investment in the country IMO. | gix er | |
15/10/2024 16:38 | siggy - unfortunately FF is unknown and remains a niche product with a miniscule market place. | redprince | |
15/10/2024 14:55 | So if you are obese and umemployed you might get pills with all the side effects (for free) so as to save some of the 11 bill. Surely FF has the potential for a similar blanket rollout to save the cost of all those strokes ? siggy | sigma3333 | |
14/10/2024 13:44 | gixer —just wish he didn’t have a competing product to us siggy | sigma3333 | |
14/10/2024 06:53 | If he is a competitor then he isn't doing a very good job. DAY 01 | MONDAY, OCTOBER 14, 2024 KEYNOTE TALKS 12:20-13:00 Title: Development Of European Food Standard Agency-Approved Cardioprotective Functional Food Ingredients From Tomato Asim K. Duttaroy, University Of Oslo, Oslo, Norway | gix er | |
13/10/2024 08:35 | Gixer the facts speak for themselves, don’t blame him, but now he is a competitor now and should be treated as such. siggy | sigma3333 | |
13/10/2024 08:15 | siggy, Not sure how you come to the conclusion that "someone on the DSM payroll has set up in competition to fruitflow" but Asim is only a scientist wanting his invention to be available to the wider world. Cant blame him for that. | gix er | |
12/10/2024 20:48 | gixer imteresting, so someone on the DSM payroll has set up in competition to fruitflow. Another reason to go it alone. Will look forward to asking the Prof what’s he up if he’s at AGM. siggy | sigma3333 | |
12/10/2024 07:39 | Not that I think its a bad thing but we would have some competition from the off in India. Asims other product invention, (Genactin?) an extract from Kiwi Fruits is already available in India although I don't know if it has passed any process allowing a health claim. The Company behind it is Genimen Pharmacon and the first, and as far as I know, the only product was launched about a year ago by Yardlab called HeartyFine by Asim himself. Looks like its had a name change already. | gix er | |
11/10/2024 18:57 | gixer very interesting. The Prof would be a good choice to push FF as is by one of their own….. siggy | sigma3333 | |
11/10/2024 08:32 | Probably these guys that would deal with health claims. | gix er | |
11/10/2024 07:36 | Without checking, I believe that there is some form of regulation on health claims in India. How involved that is I have no idea. | gix er | |
10/10/2024 21:33 | gixer I see you have posted some articles from India on lse. Do you know if India has similar regulation for functional health claims, similar to SAMR/EFSA, that could delay product releases siggy | sigma3333 | |
10/10/2024 21:27 | IF could get a lot of brownie pints if he livestreamed the AGM with Q&A. siggy | sigma3333 | |
10/10/2024 07:41 | Informer, I can say that, as usual, I will not be attending. I simply cant justify the time and cost of traveling to London for the event :( I appreciated your write up on last years AGM and hope that you can find the time to do the same again this year. Thanks. | gix er | |
10/10/2024 07:18 | Thanks informer a nice balanced view, I think we can expect another £75k from ff+ on top of that for March - sept, so in fact £800k already booked ,and £190k being processed so almost £1m revenue for 24/25 . | winner31 | |
09/10/2024 20:11 | We have by now had sufficient time to digest Finals recently published and whilst one can totally understand the negativity from those who have to shoulder a significant paper loss over several years - and clearly the increased underlying loss despite an over 100% year on year sales increase in sales does very little to inspire confidence and reverse this negative view. Should this trend continue surely we are all doomed - HOWEVER it is important to note these figures are to 31st March 2024. The figures from which we should take inspiration are those which show Fruitflow II SD sales of £ 724,000 in the six months ending 30th September 24 are significant ( £ 120,00 per month ) Also £ 190,000 of confirmed sales currently being processed ... If this should represent one months sales then this projects annual sales circa over £ 2 million. In addition Cash Burn for the year 23/24 appears to shows only £ 190k approx ??? Why has there been no call for cash since 31st March 24 ? I think we give IF little credit for the way he controls this. It will be interesting to find out at the AGM what the future cash requirement may be required for the coming 6 - 12 months. Rather hoping that a few more than the 4 of us who attended last years AGM will make the effort on the 25th | informer | |
04/10/2024 08:32 | Prices tracking down now. hxxps://www.tomatone siggy | sigma3333 | |
04/10/2024 08:29 | Another angle re margins is the cost of tomatoes has gone up significantly but this isn’t being fully passed on to customers. siggy | sigma3333 | |
03/10/2024 11:14 | RP Gross Margin was always going to fall off a cliff once the AA fell out of the equation. Pre us being responsible for sales we had FF+ contributing at ~65% GM and the AA income had no ( gross ) costs associated with it so effectively had an infinite GM. Once we're responsible for sales the whole situation changes so we get more revenue, but at a much reduced margin. In an ideal world Ford should have fleshed out his previous statements on "like for like" and pointed out that the royalties would mean our margins could well be worse. On the face of it, if revenues from FF are broadly the same now as they were under DSM then the profit share we used to take isn't currently massively different to the royalty DSM are now taking. Ford, probably via his advisors, tends to sail a bit close to the wind in making the Annual and Interims clear and unambiguous. In some ways you can see his background is numbers and not words, because the words frequently aren't helpful. On Cost Of Goods, you know better than me that it's not just the cost you bought the goods at ( or the replacement cost ) but can include storage costs and the like. It seems unusual to me to include royalties there, but it's not unheard of to do so. At least he's clarified that this time round, though it should have been made clear from the start. | bareknee | |
03/10/2024 09:34 | BB - yes i saw that but my point is we were told that under the new arrangement the terms were more favourable albeit will take 4 years to see full benefit.When you compare the previous year gross margin 75.5% v 35% for this year it is far from improving. So why on earth would any inventory cost other than that realted to cost of goods sold be included?It should not. Once again imo a deliberate opaqueness and a set of accounts that are very misleading. This is a constantly recurring theme from If and i find it more than a little annoying. | redprince | |
03/10/2024 08:38 | Red - Cost of Goods is intrinsically linked to Revenue so it going up isn't a bad thing. Looking at the accounts there's a note there on inventories saying 389k's worth of inventories were recognised as an expense under Cost of Goods. Given the Cost of Goods was 518k, that's a gap of 129k. We can't infer from that that we paid a royalty of 129k to DSM, but the royalty payment will be within that 129k. My guess is that most of that 129k is down to the royalty payment. If ( big if ) all my guesses are correct then I think we're currently running on a Gross Margin of ~30% on FF II SD which, once you strip out the royalty, would be ~50%. | bareknee | |
01/10/2024 10:38 | By health making a strong recovery hopefully some good news coming . | winner31 | |
30/9/2024 06:33 | Well those are sh@@@ | sigma3333 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions